Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 14, 2021

SELL
$4.79 - $6.68 $80,328 - $112,023
-16,770 Closed
0 $0
Q2 2021

Jul 22, 2021

SELL
$5.35 - $6.35 $27,675 - $32,848
-5,173 Reduced 23.57%
16,770 $99,000
Q1 2021

Apr 29, 2021

BUY
$5.68 - $7.87 $20,839 - $28,875
3,669 Added 20.08%
21,943 $132,000
Q4 2020

Jan 19, 2021

BUY
$5.25 - $8.56 $13,230 - $21,571
2,520 Added 16.0%
18,274 $126,000
Q3 2020

Oct 22, 2020

BUY
$5.78 - $7.47 $2,369 - $3,062
410 Added 2.67%
15,754 $99,000
Q2 2020

Aug 14, 2020

BUY
$4.5 - $7.02 $69,048 - $107,714
15,344 New
15,344 $101,000

Others Institutions Holding CERS

About CERUS CORP


  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $351M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Procyon Advisors, LLC Portfolio

Follow Procyon Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Procyon Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Procyon Advisors, LLC with notifications on news.